Sutro Biopharma doses first patient in Phase 1 trial of STRO-006 ADC

October 21, 2026 8:02 AM

Sutro Biopharma (NASDAQ: STRO) announced that the first patient has been dosed in a Phase 1 trial of STRO-006, an ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found